EPINEPHRINE NASAL SPRAY clinical trials

AN OUTPATIENT, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF THE EFFICACY OF ARS-2 IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA

This study is testing a new nasal spray treatment for chronic hives (urticaria). It's designed to see if the spray can quickly reduce itching and hives compared to a dummy spray, helping people feel better sooner.